PILE: a candidate prognostic score in cancer patients treated with immunotherapy.
Deniz Can GuvenH C YildirimE BilginO H AktepeH TabanT K SahinI Y CakirS AkinO DizdarS AksoyS YalcinM ErmanS KilickapPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2021)
In this study, we demonstrated a decreased overall survival in ICI-treated patients with a higher PILE score. If prospective studies validate our results, PILE score could be a biomarker for immunotherapy.